EXETER, N.H.--(BUSINESS WIRE)--March 8, 2006--In 2005, revenues grew 33%, net income increased 92% -
Growth of generic pharmaceutical business to support increased investments in R&D in 2006 - Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical and drug delivery company, today reported financial and operating results for the fourth quarter and year ended December 31, 2005.
